Prihlásiť sa Zaregistrujte sa zadarmo

Vlastníctvo manažmentu spoločnosti AMAG Pharmaceuticals

Aká je hodnota metriky Vlastníctvo manažmentu spoločnosti AMAG Pharmaceuticals?

Hodnota metriky Vlastníctvo manažmentu spoločnosti AMAG Pharmaceuticals, Inc. je 1.75%

Aká je definícia metriky Vlastníctvo manažmentu?



Vlastníctvo manažmentu (Insider Ownership) je pomer akcií vlastnených akcionármi v rámci firmy (vlastniaci viac než 5% spoločnosti alebo s titulom riaditeľa či vedúceho oddelenia) a všetkých vydaných akcií.

A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.

A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.

Vlastníctvo manažmentu spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou AMAG Pharmaceuticals

Čomu sa venuje spoločnosť AMAG Pharmaceuticals?

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.

Firmy s metrikou vlastníctvo manažmentu podobnou spoločnosti AMAG Pharmaceuticals